CDKN2A and neoplasm: These findings demonstrate the complexity and interaction of amplifications in the chromosome region 11q3 (activating cyclin D1) and deletion of chromosome region 9p21 (inactivation of p16), which can lead to uncontrolled proliferation and tumor progression [47].